A phase II trial of CI-921 in advanced malignancies.
Sklarin NT, Wiernik PH, Grove WR, Benson L, Mittelman A, Maroun JA, Stewart JA, Robert F, Doroshow JH, Rosen PJ, et al.
Invest New Drugs. 1992 Nov;10(4):309-12.PMID: 1487405 [PubMed - indexed for MEDLINE]Related articles